Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-30
DOI
10.1038/s41467-022-32816-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials
- (2021) F. Pietrantonio et al. ESMO Open
- Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
- (2021) Ina Valeria Zurlo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers
- (2021) Mark A. Baxter et al. BRITISH JOURNAL OF CANCER
- PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer
- (2021) Qing Li et al. MOLECULAR THERAPY
- Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images
- (2021) Wei Mu et al. Journal for ImmunoTherapy of Cancer
- Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study
- (2021) Yoshiyasu Umeda et al. EUROPEAN JOURNAL OF CANCER
- Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer
- (2021) Joao V Alessi et al. Journal for ImmunoTherapy of Cancer
- Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
- (2020) Kurt A. Schalper et al. NATURE MEDICINE
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
- (2020) Alex Zwanenburg et al. RADIOLOGY
- Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
- (2020) Houssein Abdul Sater et al. Journal for ImmunoTherapy of Cancer
- Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
- (2020) Y. Jiang et al. ANNALS OF ONCOLOGY
- Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
- (2020) A. Simonaggio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
- (2020) M. Moehler et al. ANNALS OF ONCOLOGY
- Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
- (2019) Hao Peng et al. CLINICAL CANCER RESEARCH
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
- (2019) Mohammadhadi Khorrami et al. Cancer Immunology Research
- The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications
- (2019) B. Soldevilla et al. EUROPEAN JOURNAL OF CANCER
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
- (2018) Roger Sun et al. LANCET ONCOLOGY
- Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
- (2018) Yuming Jiang et al. EBioMedicine
- Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas
- (2018) Niha Beig et al. RADIOLOGY
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Radiomics: the bridge between medical imaging and personalized medicine
- (2017) Philippe Lambin et al. Nature Reviews Clinical Oncology
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
- (2017) Yuming Jiang et al. JAMA Surgery
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- The patterns and timing of recurrence after curative resection for gastric cancer in China
- (2016) Dan Liu et al. World Journal of Surgical Oncology
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment
- (2014) Elena I. Deryugina et al. NEOPLASIA
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The tumor microenvironment controls drug sensitivity
- (2012) Arne Östman NATURE MEDICINE
- Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
- (2010) A McGarry Houghton et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now